Advance Drug Discovery with Creative Biolabs' High-Throughput Screening Solutions
Creative Biolabs uses advanced innovative technology to accelerate drug discovery and research in target-specific therapy for a wide range of diseases, including cancer, genetic disorders, and infectious diseases.New York, USA - November 25, 2024 - In recent years, the field of RNA therapeutics has emerged as a revolutionary area in biotechnology, offering promising avenues for the treatment of a multitude of diseases, including cancer, genetic disorders, and infectious diseases. Furthermore, as more and more becomes understood about the biology of RNA, its potential for gene therapy becomes obvious, resulting in growing attention by the academic and pharmaceutical sectors. Creative Biolabs has modern services and technologies that assist in the creation of cell therapeutics based on RNA. They focus on high-throughput screening techniques that allow for rapid identification of effective RNA molecules, streamlining the drug discovery process.
Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg
SiRNA technology forms an inseparable section of genetics that enables the silencing of cellular regulation mechanisms. Creative Biolabs provides services and capabilities for siRNA screening [https://www.creative-biolabs.com/gene-therapy/sirna-in-vitro-screening-service.htm], which will help select the best siRNA sequences that will downregulate targeted genes most efficiently.
"High-throughput screening in our facility allows us to discover and confirm effective siRNA-modified targets in a timeous manner," said a scientist from this company. "We assist researchers all over the world to carry out their siRNA-based projects and to achieve results that include screening and functional and kinetic analysis of the chosen targets."
Antisense oligonucleotides (ASOs) can be designed to treat a broad range of genetic diseases. Creative Biolabs assists researchers by providing ASO Screening [https://www.creative-biolabs.com/gene-therapy/aso-in-vitro-screening-service.htm] services that allow them to design suitable ASO sequences for gene expression modulation. Enhanced screening technologies allow the development of AO therapeutics with relative ease, precision and efficacy. From sequence design to acquisition of AO with desired anti-sense activity, their practice provides expertise in all aspects of ASO development.
In addition to RNA-based solutions, Creative Biolabs has wide experience in aptamer design [https://www.creative-biolabs.com/gene-therapy/custom-aptamer-design-service-for-rnai.htm] and provides custom solutions to fit the specific requirements of each project.
"Aptamers are molecular tools that are specially engineered for use in diagnostics, therapeutics, and other areas. Our patented aptamer selection and optimization procedures ensure the discovery of aptamers with excellent affinity and specificity. With our expertise, researchers are in a position to design aptamers that bind selectively to specific types of molecules," emphasized the scientist.
As a trusted partner in therapeutics development, Creative Biolabs is dedicated to offering innovative and tailored solutions for our customers to ensure the effects of their projects. Their mission is to provide strong support to customers' research projects with expertise and cutting-edge development platforms.
Learn more information about services regarding RNA therapeutics research, please visit https://www.creative-biolabs.com/gene-therapy.
About Creative Biolabs
Creative Biolabs is a biotechnology company based in US, focusing on the development of efficient solutions for biomedical studies and drug discovery and development. With the commitment to advancing RNA therapeutics, the company delivers siRNA screening, ASO screening, and aptamer design services to enhance customers' research projects for new therapies.
Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email [http://www.universalpressrelease.com/?pr=advance-drug-discovery-with-creative-biolabs-highthroughput-screening-solutions]
Phone: 1-631-830-6441
Country: United States
Website: https://www.creative-biolabs.com/gene-therapy
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advance Drug Discovery with Creative Biolabs' High-Throughput Screening Solutions here
News-ID: 3757428 • Views: …
More Releases from Getnews
Best Choice Roofing Expands Services in Williamsburg, Offering Premier Roofing S …
Image: https://www.globalnewslines.com/uploads/2025/01/1737388686.jpg
Best Choice Roofing has announced its enhanced roofing services for the Williamsburg area, providing exceptional solutions to meet residential and commercial roofing needs. Known for its commitment to quality craftsmanship and reliability, the company is now a go-to option for homeowners and businesses seeking trusted roofing professionals.
With a focus on delivering superior results, Best Choice Roofing has become a leading name for those searching for a Roofer Near Me…
Variant Roofing Expands Professional Roofing Services in Denham Springs
Image: https://www.globalnewslines.com/uploads/2025/01/1737380228.jpg
Variant Roofing, a trusted provider of professional roofing services, has announced an expansion of its offerings to better serve homeowners and businesses in the Area. Known for its commitment to quality and reliability, the company provides tailored solutions for various roofing needs, from repairs and maintenance to assistance with insurance claims.
Reliable Roof Repair Services
Variant Roofing specializes in addressing a variety of roofing issues, from minor leaks to extensive storm…
How to Choose the Right Pump for a Fountain Pond?
Image: https://www.globalnewslines.com/uploads/2025/01/1737023714.jpg
A fountain pond is a perfect addition to your outdoor space, combining the soothing sounds of water with a visually striking feature. It can be a small garden pond or a large decorative water feature, but the right pump is essential for keeping it functional, beautiful, and healthy.
If you plan to buy pumps for fountains [https://www.fountaintechpumps.com/outdoor-pond-pumps/], this guide will help you make an informed decision.
Why Do You Need a…
The Venue RX Podcast Features Spencer Howard: "How CEOs Can Play Chess - Not Che …
Image: https://authoritypresswire.com/wp-content/uploads/2025/01/Spencer_Howard_Headshot-removebg-preview.png
The Venue RX Podcast [https://podcasts.apple.com/us/podcast/how-ceos-can-play-chess-not-checkers-the-venue-rx/id1539359777?i=1000657754210], hosted by Jonathan Aymin, welcomes Spencer Howard [https://straighttothepoints.co/], founder of Straight to the Points , to discuss how CEOs and business owners can make strategic financial moves using credit card points and travel rewards. In the episode, titled "How CEOs Can Play Chess - Not Checkers," Howard breaks down actionable strategies for entrepreneurs to optimize rewards systems, manage expenses, and leverage points for business…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…